Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis.
Ravn P, Neugebauer G, Christiansen C.
Bone. 2002 Jan;30(1):320-4.
Similar articles
Current clinical use of reteplase for thrombolysis. A pharmacokinetic-pharmacodynamic perspective.
Martin U, Kaufmann B, Neugebauer G.
Clin Pharmacokinet. 1999 Apr;36(4):265-76. Review.
Systematic screening for pharmacokinetic interactions during drug development.
Fuhr U, Weiss M, Kroemer HK, Neugebauer G, Rameis H, Weber W, Woodcock BG.
Int J Clin Pharmacol Ther. 1996 Apr;34(4):139-51. Review.
General relativistic gravitational field of a rigidly rotating disk of dust: solution in terms of ultraelliptic functions.
Neugebauer G, Meinel R.
Phys Rev Lett. 1995 Oct 23;75(17):3046-3047. No abstract available.
General relativistic gravitational field of a rigidly rotating disk of dust: Axis potential, disk metric, and surface mass density.
Phys Rev Lett. 1994 Oct 17;73(16):2166-2168. No abstract available.
Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans.
de Mey C, Breithaupt K, Schloos J, Neugebauer G, Palm D, Belz GG.
Clin Pharmacol Ther. 1994 Mar;55(3):329-37.
Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction.
Neugebauer G, Gabor M, Reiff K.
J Cardiovasc Pharmacol. 1992;19 Suppl 1:S142-6.
Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator bm 06.022 in healthy volunteers.
Martin U, von Möllendorff E, Akpan W, Kientsch-Engel R, Kaufmann B, Neugebauer G.
Thromb Haemost. 1991 Nov 1;66(5):569-74.
Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers.
Clin Pharmacol Ther. 1991 Oct;50(4):429-36.
Metabolism of carvedilol in man.
Neugebauer G, Neubert P.
Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):257-60.
Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.
Neugebauer G, Akpan W, Kaufmann B, Reiff K.
Eur J Clin Pharmacol. 1990;38 Suppl 2:S108-11.
Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
Neugebauer G, Raedsch R, Stiehl A, Kaufmann B, Besenfelder E, Neubert P, Walter-Sack I.
Arzneimittelforschung. 1989 Oct;39(10A):1343-7.
Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
Wittenbrink-Dix AM, Neugebauer G, Fuhr U, Neubert P, Besenfelder E, Woelke-Seidl E, Harder S, Staib AH.
Arzneimittelforschung. 1989 Oct;39(10A):1339-43.
Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans.
Neugebauer G, Wittenbrink-Dix AM, Woelke-Seidl E, Kaufmann B, Ponton T, Dahmen W, Mosberg H, Nieder N, Besenfelder E.
Arzneimittelforschung. 1989 Oct;39(10A):1336-9.
Performance of a slow-release formulation of isosorbide-5-mononitrate (ISMO retard).
Neugebauer G, Akpan W, Stemmle B, Jaeger H, Mosberg H, Lutz D.
Int J Clin Pharmacol Ther Toxicol. 1989 Jan;27(1):34-8.
Steady-state kinetics of bezafibrate retard in hyperlipidemic geriatric patients.
Neugebauer G, Platt D, Vömel T, Lösch W.
Klin Wochenschr. 1988 Mar 15;66(6):250-6.
Pharmacokinetics and metabolism of torasemide in man.
Neugebauer G, Besenfelder E, von Möllendorff E.
Arzneimittelforschung. 1988 Jan;38(1A):164-6.
[From the nail/plate to the dynamic hip screw--example of a generation change in implants for para-articular femoral fractures].
Kohlmann H, Vécsei V, Neugebauer G, Gottsauner-Wolf F.
Wien Klin Wochenschr. 1987 Oct 9;99(19):677-82. German.
Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker.
von Möllendorff E, Reiff K, Neugebauer G.
Eur J Clin Pharmacol. 1987;33(5):511-3.
Pharmacokinetics and disposition of carvedilol in humans.
Neugebauer G, Akpan W, von Möllendorff E, Neubert P, Reiff K.
J Cardiovasc Pharmacol. 1987;10 Suppl 11:S85-8.
Influence of beta-blocker coadministration on the kinetics of isosorbide mononitrate and dinitrate.
Ochs HR, Neugebauer G, Greenblatt DJ, Labedzki L.
Klin Wochenschr. 1986 Dec 1;64(23):1213-6.
Clinical pharmacologic investigations with carvedilol, a new beta-blocker with direct vasodilator activity.
von Möllendorff E, Abshagen U, Akpan W, Neugebauer G, Schröter E.
Clin Pharmacol Ther. 1986 Jun;39(6):677-82.
The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177.
Patscheke H, Staiger C, Neugebauer G, Kaufmann B, Strein K, Endele R, Stegmeier K.
Clin Pharmacol Ther. 1986 Feb;39(2):145-50.
Single dose pharmacokinetics and effects on platelet function of the thromboxane receptor blocker BM 13.177.
Staiger C, Patscheke H, Neugebauer G, Kaufmann B, Strein K, Endele R, Stegmeier K.
Eur J Clin Pharmacol. 1986;29(5):573-9.
Digital pulse plethysmography--a tool for investigating vasoactive substances.
von Möllendorff E, Neugebauer G.
Methods Find Exp Clin Pharmacol. 1985 Sep;7(9):501-10.
Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N).
Neugebauer G, Betzien G, Hrstka V, Kaufmann B, von Möllendorff E, Abshagen U.
Int J Clin Pharmacol Ther Toxicol. 1985 Sep;23(9):453-60.
Computer-generated holograms: carrier of polar geometry.
Neugebauer G, Hauck R, Bryngdahl O.
Appl Opt. 1985 Mar 15;24(6):777. No abstract available.
Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U, Betzien G, Endele R, Kaufmann B, Neugebauer G.
Eur J Clin Pharmacol. 1985;27(6):637-44.
Early results from the infrared astronomical satellite.
Neugebauer G, Beichman CA, Soifer BT, Aumann HH, Chester TJ, Gautier TN, Gillett FC, Hauser MG, Houck JR, Lonsdale CJ, Low FJ, Young ET.
Science. 1984 Apr 6;224(4644):14-21.
A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
Kaumeier HS, Kehrhahn OH, Neugebauer G, Schuppan D, Schwarz JA, Staib AH.
Arzneimittelforschung. 1984;34(1):92-5.
Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Patscheke H, Stegmeier K, Müller-Beckmann B, Sponer G, Staiger C, Neugebauer G.
Biomed Biochim Acta. 1984;43(8-9):S312-8.
A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets).
Int J Clin Pharmacol Ther Toxicol. 1983 Jul;21(7):339-45.
Pharmacodynamic and pharmacokinetic evaluation in man of the new sympathomimetic amezinium.
Neugebauer G, Kaumeier HS, Kehrhahn OH, Morgenthaler H.
Eur J Clin Pharmacol. 1983;24(2):185-90.
Beta-blocking and electrophysiological effects of propafenone in volunteers.
Müller-Peltzer H, Greger G, Neugebauer G, Hollmann M.
Eur J Clin Pharmacol. 1983;25(6):831-3.
[Interaction of guar with glibenclamide and bezafibrate].
Neugebauer G, Akpan W, Abshagen U.
Beitr Infusionther Klin Ernahr. 1983;12:40-7. German. No abstract available.
[Preoperative diagnosis of a Meckel's diverticulum (author's transl)].
Neugebauer G.
Wien Klin Wochenschr. 1981 Nov 27;93(22):701-2. German.
Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
Kaumeier S, Kehrhahn OH, Morgenthaler H, Neugebauer G.
Arzneimittelforschung. 1981;31(9a):1653-7.
Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine.
Wilsmann K, Neugebauer G, Kessel R, Lang E.
Arzneimittelforschung. 1981;31(9a):1647-52.
Haemodynamic effects of amezinium in man.
Arzneimittelforschung. 1981;31(9a):1638-46.
Pioneer saturn infrared radiometer: preliminary results.
Ingersoll AP, Orton GS, Münch G, Neugebauer G, Chase SC.
Science. 1980 Jan 25;207(4429):439-43.
Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.
Cardiovasc Res. 1978 Apr;12(4):247-54. No abstract available.
Viking first encounter of phobos: preliminary results.
Tolson RH, Duxbury TC, Born GH, Christensen EJ, Diehl RE, Farless D, Hildebrand CE, Mitchell RT, Molko PM, Morabito LA, Palluconi FD, Reichert RJ, Taraji H, Veverka J, Neugebauer G, Findlay JT.
Science. 1978 Jan 6;199(4324):61-4.
[Cardiac effects, relative enteral effectiveness and rate of inactivation of the cardiac glycoside meproscillarin].
Raschack M, Haas H, Neugebauer G, Sipos J.
Arzneimittelforschung. 1978;28(3a):495-502. German. No abstract available.
Infrared studies of star formation.
Werner MW, Becklin EE, Neugebauer G.
Science. 1977 Aug 19;197(4305):723-32. No abstract available.
[Influence of high intravenous doses of D-penicillamine on toxic actions of cardiac glycosides in the guinea pig. Short communication (author's transl)].
Arzneimittelforschung. 1977;27(11):2073-4. German.
[Improvement of flow properties using Arwin in acute experimental infarct].
Z Kardiol. 1976 Nov;65(11):1010-21. German.
[Splenectomy for traumatic rupture of the spleen in childhood and its sequaelae].
Passl R, Eibl M, Egkher E, Frisee H, Gaudernak T, Neugebauer G, Vécsei W.
Wien Klin Wochenschr. 1976 Oct 1;88(78):585-8. German.
Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog.
Schaper W, Flameng W, Winkler B, Wüsten B, Türschmann W, Neugebauer G, Carl M, Pasyk S.
Circ Res. 1976 Sep;39(3):371-7.
Infrared thermal mapping of the martian surface and atmosphere: first results.
Kieffer HH, Chase SC Jr, Miner ED, Palluconi FD, Münch G, Neugebauer G, Martin TZ.
Science. 1976 Aug 27;193(4255):780-6.
Pioneer 11 infrared radiometer experiment: the global heat balance of jupiter.
Ingersoll AP, Münch G, Neugebauer G, Diner DJ, Orton GS, Schupler B, Schroeder M, Chase SC, Ruiz RD, Trafton LM.
Science. 1975 May 2;188(4187):472-3.
Filters: Manage Filters